Glucotrack, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Glucotrack, Inc. amended its Certificate of Incorporation effective August 28, 2026, to execute a 15-for-1 reverse stock split of common stock (each 15 old shares become 1 new share) and increased authorized preferred stock from unspecified prior level to 10,000,000 shares, par value $0.001 per share. Authorized common stock remains at 250,000,000 shares post-split. Fractional shares are rounded up to whole shares. No specific share count, shareholder impact dollar amount, or prior authorized share counts are disclosed in the filing.
Why this rating
Reverse splits and preferred authorization expand are common but material governance actions; split severity (15:1) suggests potential prior stock weakness relative to micro-cap size; neutral absent dilution detail.
Price action (we called it neutral)
before filing · preread $0.28 ▲ 0.04% | at our read · backfill $0.28 | +10 min · backfill $0.28 ▼ 1.37% | +30 min · backfill $0.28 ▼ 3.13% | +1 hr · backfill $0.28 ▼ 0.85% |
The stock had already moved -0.04% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.